SG64895A1 - New use of bambuterol - Google Patents

New use of bambuterol

Info

Publication number
SG64895A1
SG64895A1 SG1996005904A SG1996005904A SG64895A1 SG 64895 A1 SG64895 A1 SG 64895A1 SG 1996005904 A SG1996005904 A SG 1996005904A SG 1996005904 A SG1996005904 A SG 1996005904A SG 64895 A1 SG64895 A1 SG 64895A1
Authority
SG
Singapore
Prior art keywords
bambuterol
new use
manufacture
pharmaceutically acceptable
acceptable salt
Prior art date
Application number
SG1996005904A
Other languages
English (en)
Inventor
Carl-Axel Bauer
Leif Ake Svensson
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of SG64895A1 publication Critical patent/SG64895A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
SG1996005904A 1990-03-16 1991-03-14 New use of bambuterol SG64895A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9000948A SE9000948D0 (sv) 1990-03-16 1990-03-16 New use

Publications (1)

Publication Number Publication Date
SG64895A1 true SG64895A1 (en) 2000-01-25

Family

ID=20378886

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996005904A SG64895A1 (en) 1990-03-16 1991-03-14 New use of bambuterol

Country Status (28)

Country Link
US (2) US5837727A (ru)
EP (1) EP0521967B1 (ru)
JP (1) JP3081640B2 (ru)
KR (1) KR100194995B1 (ru)
AT (1) ATE138570T1 (ru)
AU (1) AU653149B2 (ru)
CA (1) CA2077762C (ru)
CZ (1) CZ279308B6 (ru)
DE (1) DE69119896T2 (ru)
DK (1) DK0521967T3 (ru)
EG (1) EG19645A (ru)
ES (1) ES2087291T3 (ru)
GR (1) GR3020700T3 (ru)
HK (1) HK52197A (ru)
HU (1) HU211998B (ru)
IE (1) IE80668B1 (ru)
IL (1) IL97509A (ru)
LT (1) LT3734B (ru)
LV (1) LV10917B (ru)
MY (1) MY114218A (ru)
NZ (1) NZ237279A (ru)
PT (1) PT97052B (ru)
RU (1) RU2093153C1 (ru)
SE (1) SE9000948D0 (ru)
SG (1) SG64895A1 (ru)
SK (1) SK278815B6 (ru)
WO (1) WO1991013615A1 (ru)
ZA (1) ZA911452B (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9000948D0 (sv) * 1990-03-16 1990-03-16 Draco Ab New use
US6459316B1 (en) * 2000-12-08 2002-10-01 Intel Corporation Flip flop circuit
US7067517B2 (en) * 2001-12-14 2006-06-27 Nero Nordisk A/S Use of compounds for decreasing activity of hormone-sensitive lipase
US7495028B2 (en) 2002-08-08 2009-02-24 Wen Tan R-bambuterol, its preparation and therapeutic uses
AU2002332488A1 (en) * 2002-08-08 2004-02-25 J. L. Cheng R-bambuterol, its preparation and therapeutic uses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0043807B1 (en) * 1980-07-09 1984-05-30 Aktiebolaget Draco 1-(dihydroxyphenyl)-2-amino-ethanol derivatives; preparation, compositions and intermediates
US4472436A (en) * 1982-12-06 1984-09-18 Neo-Bionics, Inc. Increasing HDL-cholesterol levels with phenylethylamine derivatives
EP0244062A3 (en) * 1986-03-03 1990-06-20 Beecham Group Plc Use of aryl ethanol amine derivatives in the treatment of atherosclerosis
SE9000948D0 (sv) * 1990-03-16 1990-03-16 Draco Ab New use

Also Published As

Publication number Publication date
DE69119896T2 (de) 1996-10-10
JPH05504971A (ja) 1993-07-29
ATE138570T1 (de) 1996-06-15
LT3734B (en) 1996-02-26
AU653149B2 (en) 1994-09-22
PT97052B (pt) 1998-07-31
LV10917B (en) 1996-04-20
GR3020700T3 (en) 1996-10-31
WO1991013615A1 (en) 1991-09-19
HUT61461A (en) 1993-01-28
KR100194995B1 (ko) 1999-06-15
LV10917A (lv) 1995-12-20
NZ237279A (en) 1993-08-26
MY114218A (en) 2002-09-30
IL97509A0 (en) 1992-06-21
ZA911452B (en) 1991-11-27
EP0521967A1 (en) 1993-01-13
JP3081640B2 (ja) 2000-08-28
ES2087291T3 (es) 1996-07-16
EG19645A (en) 1995-09-30
DK0521967T3 (da) 1996-09-09
CA2077762C (en) 2001-06-12
CS9100681A2 (en) 1991-10-15
CZ279308B6 (cs) 1995-04-12
HU211998B (en) 1996-01-29
PT97052A (pt) 1991-10-31
SK278815B6 (sk) 1998-03-04
HU9202958D0 (en) 1992-12-28
LTIP1735A (en) 1995-07-25
HK52197A (en) 1997-05-02
IE80668B1 (en) 1998-11-18
DE69119896D1 (de) 1996-07-04
EP0521967B1 (en) 1996-05-29
RU2093153C1 (ru) 1997-10-20
US6034123A (en) 2000-03-07
AU7569191A (en) 1991-10-10
US5837727A (en) 1998-11-17
SE9000948D0 (sv) 1990-03-16
IL97509A (en) 1995-12-31
IE910862A1 (en) 1991-09-25
CA2077762A1 (en) 1991-09-17

Similar Documents

Publication Publication Date Title
AU580262B2 (en) Drug administration
HU912266D0 (en) Process for the production of solid medical preparations with controlled portioning of the active agents for oral use
ES510348A0 (es) "procedimiento de preparacion de nuevos derivados 3,4-dihidro-5h-2,3-benzodiazepinos y de sus sales de adicion acidas farmaceuticamente aceptables".
AU650484B2 (en) Isoxazole compound, pharmaceutically acceptable salt thereof, and medicinal use thereof
JPS5661310A (en) Nutritious drug for nonoral administration
DE3880667D1 (de) Ampulle zur gesteuerten verabreichung eines heilmittels.
NO874850D0 (no) Fremgangsmaate for fremstilling av benzotiadiazinforbindelser og farmasoeytisk akseptable salter derav.
SG64895A1 (en) New use of bambuterol
EP0650723A3 (en) New pharmaceutical uses of forskolin derivatives.
NO913187D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tricykliske derivater.
JO1692B1 (en) Use of a pharmaceutically acceptable salt
HU9300388D0 (en) New medical preparatives with 5-(1-hydroxi-2-chlorine-ethyl)-4-methyl-triazole content and method for preparing them
NO900972D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive naftalen-derivater.
SE9000288D0 (sv) New use
JO1658B1 (en) New vehicles
PH30736A (en) Process for the preparation of a stable pharmaceutical suspension.
ZA917309B (en) New oral drug forms
ZA912858B (en) New pharmacologically active catechol derivatives
GB9004360D0 (en) New pharmaceutical use
GB9023656D0 (en) New pharmaceutical use
GB9021241D0 (en) New pharmaceutical use
GB9014231D0 (en) New pharmaceutical use
GB9014230D0 (en) New pharmaceutical use
FI935388A0 (fi) Menetelmä lääkeaineena käyttökelpoisen bentsimidatsolidipyridiniumjohdannaisten valmistamiseksi
NO890506L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kloranilin-derivater.